Publications

Research & Development

• Clinical Programs
  Transcriptional Regulation: CDK Inhibitors
  • CYC065
  • Seliciclib (CYC202)
  DNA Damage Response
  • Sapacitabine (CYC682) & seliciclib
  Sapacitabine in Hematology
• Other programs
• Science and Technology
  • Cell Cycle in Cancer
• Clinical Trials
• Publications